Envestnet Asset Management
PRAX icon

Envestnet Asset Management’s Praxis Precision Medicines PRAX Stock Holding History

Envestnet Asset Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.4M Sell
4,179
-683
-14% -$216K ﹤0.01% 3409
2026
Q1 		$1.57M Sell
4,862
-688
-12% -$213K ﹤0.01% 3175
2025
Q4 		$1.64M Buy
+5,550
New +$1.03M ﹤0.01% 2972
2025
Q1 		– Sell
-3,008
Closed -$231K – 4447
2024
Q4 		$231K Buy
+3,008
New +$218K ﹤0.01% 4022

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Envestnet Asset Management's PRAX Position: Q2 2026 in Review

Envestnet Asset Management reduced its Praxis Precision Medicines (PRAX) stake by 14% in Q2 2026, selling an estimated $216K and leaving 4,179 shares worth $1.4M. The position accounts for ﹤0.01% of the portfolio, ranked #3409.

Envestnet Asset Management first reported a position in PRAX in Q4 2024 and has held it in 4 quarters since. The position peaked at $1.64M in Q4 2025. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Envestnet Asset Management held 4,179 shares of Praxis Precision Medicines worth $1.4M as of Q2 2026.
  • Envestnet Asset Management sold 683 Praxis Precision Medicines shares in Q2 2026, an estimated $216K.
  • Praxis Precision Medicines made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #3409 holding.
  • Envestnet Asset Management first reported a position in Praxis Precision Medicines in Q4 2024 and has held it in 4 quarters since.
  • Envestnet Asset Management's Praxis Precision Medicines position peaked at $1.64M in Q4 2025.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.